Fingerprint
Dive into the research topics of 'High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer.'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer.
Research output: Contribution to journal › Article › peer-review